Sagent Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SAGENT PHARMS INC, and what generic and branded alternatives to SAGENT PHARMS INC drugs are available?
SAGENT PHARMS INC has fifty-six approved drugs.
Drugs and US Patents for Sagent Pharms Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sagent Pharms Inc | OCTREOTIDE ACETATE | octreotide acetate | INJECTABLE;INJECTION | 091041-002 | Nov 12, 2013 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Sagent Pharms Inc | AMPICILLIN SODIUM | ampicillin sodium | INJECTABLE;INJECTION | 090583-004 | Nov 27, 2015 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Sagent Pharms Inc | GEMCITABINE HYDROCHLORIDE | gemcitabine hydrochloride | INJECTABLE;INJECTION | 209077-002 | Jul 20, 2018 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Sagent Pharms Inc | IBANDRONATE SODIUM | ibandronate sodium | INJECTABLE;INTRAVENOUS | 202235-001 | Sep 2, 2014 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Sagent Pharms Inc | FLUOROURACIL | fluorouracil | INJECTABLE;INJECTION | 203608-001 | May 11, 2017 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Sagent Pharms Inc | PENTOBARBITAL SODIUM | pentobarbital sodium | INJECTABLE;INJECTION | 206404-001 | May 23, 2016 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Sagent Pharms Inc | METHYLPREDNISOLONE SODIUM SUCCINATE | methylprednisolone sodium succinate | INJECTABLE;INJECTION | 040888-002 | Jul 18, 2011 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.